# Guangzhou Hanpu Pharmaceutical Co. Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/guangzhou-hanpu-pharmaceutical-co-ltd/aa9e3246-019e-49cc-b473-391a75a82fd2

> Inspection records and compliance data for Guangzhou Hanpu Pharmaceutical Co. Ltd. in Guangzhou, None. Access full analysis and detailed observations.

---

## Details

- Name: Guangzhou Hanpu Pharmaceutical Co. Ltd.
- FEI Number: 3007088627
- City: Guangzhou
- State: None
- Country Name: China
- Address Line 1: No 9 Jufeng North Road, Aotou, Conghua City
- Zip Code: None

## Related Documents

- [483 - Guangzhou Hanpu Pharmaceutical Co. Ltd. - 2024-12-13](https://www.keypedia.com/records/483/guangzhou-hanpu-pharmaceutical-co-ltd/3967ed5b-b1b6-46e7-8a7b-899828d2f735) — source: FDA, date: December 13, 2024
- [FDA Inspection 1259306 - Guangzhou Hanpu Pharmaceutical Co. Ltd. - 2024-12-13](https://www.keypedia.com/records/fda_inspections/guangzhou-hanpu-pharmaceutical-co-ltd/8b867b50-e30f-4683-8c8d-1ee5039547aa) — source: FDA, date: December 13, 2024
- [FDA Inspection 1259306 - Guangzhou Hanpu Pharmaceutical Co. Ltd. - 2024-12-13](https://www.keypedia.com/records/fda_inspections/guangzhou-hanpu-pharmaceutical-co-ltd/b3bd1b3e-9e33-4e7c-8c61-3a783e4dd0da) — source: FDA, date: December 13, 2024
- [FDA Inspection 1259306 - Guangzhou Hanpu Pharmaceutical Co. Ltd. - 2024-12-13](https://www.keypedia.com/records/fda_inspections/guangzhou-hanpu-pharmaceutical-co-ltd/cf924930-ab6d-4803-8751-4897577e6b7d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 13, 2024
- [FDA Inspection 1259306 - Guangzhou Hanpu Pharmaceutical Co. Ltd. - 2024-12-13](https://www.keypedia.com/records/fda_inspections/guangzhou-hanpu-pharmaceutical-co-ltd/31388595-eb1c-4fb2-8f98-c59d6ca9e471) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 13, 2024
- [FDA Inspection 1040600 - Guangzhou Hanpu Pharmaceutical Co. Ltd. - 2018-01-25](https://www.keypedia.com/records/fda_inspections/guangzhou-hanpu-pharmaceutical-co-ltd/d4994f8c-1692-4e93-8724-ee9e297c2f38) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 25, 2018
- [FDA Inspection 844182 - Guangzhou Hanpu Pharmaceutical Co. Ltd. - 2013-07-19](https://www.keypedia.com/records/fda_inspections/guangzhou-hanpu-pharmaceutical-co-ltd/b08da9cb-d8da-4141-bb5f-10a8ee6c2fc4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2013

## Related Companies

- [Strem Chemicals, Inc.](https://www.keypedia.com/companies/strem-chemicals-inc/285a934f-0fb3-4204-8233-4b3fc4364d64)
- [ISP Chemicals LLC](https://www.keypedia.com/companies/isp-chemicals-llc/8523c955-e979-40c7-afae-92f881ffe0d0)
- [Nanhai Beisha Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/nanhai-beisha-pharmaceutical-co-ltd/26bc6ed1-b4ef-4c70-9983-30dbb8e592dd)
- [Somerville Acquisitions, Inc.](https://www.keypedia.com/companies/somerville-acquisitions-inc/195f0557-96af-4562-98e7-9e03150b33cb)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/042118cf-4e9b-432b-b155-94c2b5e3e025)
- [HEC Pharm Co., Ltd.](https://www.keypedia.com/companies/hec-pharm-co-ltd/23b5826b-1111-4f49-a0ff-3b8731995caf)
- [Albemarle US, Inc.](https://www.keypedia.com/companies/albemarle-us-inc/336600a7-808b-4d7d-bfc0-7a9e728aa0aa)
- [Calyx Chemicals & Pharmaceuticals Limited](https://www.keypedia.com/companies/calyx-chemicals-pharmaceuticals-limited/e01c292e-7fb4-4afa-b74e-c1afc698d94d)
- [BASF Corporation](https://www.keypedia.com/companies/basf-corporation/66c1d1cd-8b92-4631-b68d-5e8932ea9c42)
- [Wuhan Biocause Pharmaceutical Development Co., Ltd.](https://www.keypedia.com/companies/wuhan-biocause-pharmaceutical-development-co-ltd/79c352a3-22a2-471e-abbe-1802683656eb)

## Related Officers

- [Consumer Safety Officer](https://www.keypedia.com/people/steven-a-brettler/2a356468-f9da-4b68-a3a1-472567e58e45)